Basket

  Untick selected:   0
  1. Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses / Brodowicz T., Spanik S. ... [et al.]. Onkológia Roč. 10, č. 6 (2015), s. 402-403
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.